Absci (ABSI) Treasury Shares (2020 - 2026)
Absci (ABSI) posted Treasury Shares of $5.0 million for Q1 2026, up 32.32% sequentially from $3.8 million in Q4 2025, and up 14.36% YoY from $4.4 million in Q1 2025.
Absci (ABSI) Treasury Shares (2020 - 2026) Analysis & Trends
Absci has reported Treasury Shares for 7 years, with the latest figure at $5.0 million in Q1 2026.
- Quarterly Treasury Shares rose 14.36% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (up 14.36% YoY) and the FY2025 annual result came in at $3.8 million, up 2.1% from the prior year.
- Treasury Shares improved to $5.0 million in Q1 2026 per ABSI's latest filing, from $3.8 million in the prior quarter.
- Over five years, Treasury Shares peaked at $5.0 million in Q1 2026 and troughed at $394736.0 in Q3 2023.
- A 5-year average of $2.5 million and a median of $2.2 million in 2023 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2023 and 2025: Treasury Shares sank 76.64% in 2023, then soared 1015.43% in 2025.
- Over 5 years, Treasury Shares stood at $1.0 million in 2022, then jumped by 116.95% to $2.2 million in 2023, then soared by 68.84% to $3.7 million in 2024, then grew by 2.1% to $3.8 million in 2025, then jumped by 32.32% to $5.0 million in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $5.0 million, $3.8 million, and $4.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Absci | 1.58 Bn | 1.37 Bn | - | 4.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.50 Mn |
| Jun 30, 2026 | 4.50 Mn |
| Mar 31, 2026 | 5.01 Mn |
| Mar 31, 2026 | 5.01 Mn |
| Dec 31, 2025 | 3.79 Mn |
| Dec 31, 2025 | 3.79 Mn |
| Sep 30, 2025 | 4.42 Mn |
| Sep 30, 2025 | 4.42 Mn |
| Jun 30, 2025 | 4.40 Mn |
| Jun 30, 2025 | 4.40 Mn |
| Mar 31, 2025 | 4.38 Mn |
| Mar 31, 2025 | 4.38 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Sep 30, 2024 | 4.35 Mn |
| Sep 30, 2024 | 4.35 Mn |
| Jun 30, 2024 | 394,736.00 |
| Jun 30, 2024 | 394,736.00 |
| Mar 31, 2024 | 394,736.00 |
| Mar 31, 2024 | 394,736.00 |